摘要 |
THE PRESENT INVENTION RELATES TO NOVEL IMIDAZOLIDINE DERIVATIVES OF THE FORMULA I, IN WHICH B, E, W, Y, R, R2, R3, R30, E AND H HAVE THE MEANINGS GIVEN HEREIN. THE COMPOUNDS OF THE FORMULA I ARE VALUABLE PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH ARE SUITABLE, FOR EXAMPLE, FOR TREATING INFLAMMATORY DISEASES, FOR EXAMPLE, RHEUMATOID ARTHRITIS, OR ALLERGIC DISEASES. THE COMPOUNDS OF THE FORMULA I ARE INHIBITORS OF THE ADHESION AND MIGRATION OF LEUKOCYTES AND/OR ANTAGONISTS OF THE ADHESION RECEPTOR VLA-4, WHICH BELONGS TO THE INTEGRIN GROUP. THEY ARE GENERALLY SUITABLE FOR TREATING DISEASES WHICH ARE CAUSED BY, OR ASSOCIATED WITH, AN UNDESIRABLE DEGREE OF LEUKOCYTE ADHESION AND/OR LEUKOCYTE MIGRATION OR IN WHICH CELL-CELL OR CELL-MATRIX INTERACTIONS,WHICH ARE BASED ON THE INTERACTIONS OF VLA-4 RECEPTORS WITH THEIR LIGANDS, PLAY A ROLE. THE INVENTION FURTHERMORE RELATES TO PROCESSES FOR PREPARING THE COMPOUNDS OF THE FORMULA I, TO THEIR USE AND TO PHARMACEUTICAL PREPARATIONS WHICH COMPRISE COMPOUNDS OF THE FORMULA I. |